The numbers tell a story that most international investors have not yet fully absorbed. Brazil’s medical cannabis market generated R$953 million in revenue in…
Read MoreBrazil’s ANVISA Publishes 5 New Cannabis Resolutions: What RDC 1,012 to 1,015 Mean for the Industry
Brazil’s ANVISA voted on January 28, 2026 to approve five new cannabis resolutions–RDC 1,011 through RDC 1,015–marking the most significant regulatory shift in the country’s medical cannabis market since 2019. Here’s what each resolution means for producers and operators.
Read More
